Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Vaccine. 2010 Dec 16;29(6):1201–1210. doi: 10.1016/j.vaccine.2010.12.004

TABLE 1.

Data inputs for model variables

Variable Mean Source
Probability

Risk of Hookworm Infection
0–9 years old 0.60 [13]
10–19 years old 0.76 [13]
20–59 years old 0.73 [13]
60 years old and older 0.70 [13]
Risk of Hookworm Infection being Heavy Intensity
0–2 years old 0.00 [52]
3–5 years old 0.05 [52]
6–10 years old 0.08 [52]
11–15 years old 0.08a [52]
16–20 years old 0.10 [52]
21–30 years old 0.13 [52]
31–40 years old 0.12 [52]
41–50 years old 0.03 [52]
51 years old and older 0.23 [52]
Anemia
School-age Children 0.01 [11]
Women of Reproductive Age 0.30 [9]
Anemia from Heavy Intensity Infection
5–19 years old 0.17 [53]
20 years old and older 0.09 [53]
 Anemia from Light Intensity 0.03 [53]
Infection
Albendazole Cure Rate b 0.76 (Range: 0.57 to 0.95) [36]
Albendazole Egg Reduction b 0.93 (Range: 0.79 to 0.99) [36]
Crude Mortality Rate 0.01 [54]

    Costs (2010 US$)

Community 0.63 [12, 16]
School 0.05 [1, 12]
Albendazole 0.06 [1]

Effectiveness

Life Expectancy
0 –12 months old 71.70 [32]
1–4 years old 72.00 [32]
5–9 years old 68.10 [32]
10–14 years old 63.20 [32]
15 –19 years old 58.30 [32]
20–24 years old 53.7 [32]
25 –29 years old 49.1 [32]
30–34 years old 44.6 [32]
35–39 years old 40.0 [32]
40–44 years old 35.6 [32]
45–49 years old 31.2 [32]
50–54 years old 27.0 [32]
55–59 years old 23.0 [32]
60–64 years old 19.2 [32]
65–69 years old 15.8 [32]
70–74 years old 12.6 [32]
75–79 years old 9.9 [32]
80–84 years old 7.5 [32]
85–89 years old 5.6 [32]
90–94 years old 4.0 [32]
95–99 years old 2.8 [32]
100 years old and older 2.1 [32]
DALY Disability Weights
Anemia 0.024 [38]
Heavy Intensity Infection 0.006 [38]
Cognitive Impairment 0.024 [38]

Misc

Hemoglobin Cut-offs for Anemia (g/dL)
Children 11.5 [42]
Women of Reproductive Age 12.0 [42]
a

Extrapolated from 6–10 age group

b

Triangular distribution